The gut microbiota during tamoxifen therapy in patients with breast cancer

The gut microbiota during tamoxifen therapy in patients with breast cancer

Abstract Tamoxifen is essential in treating estrogen receptor-positive (ER+) breast cancer, primarily through its active metabolite, endoxifen. Emerging research suggests potential interactions between tamoxifen and gut microbiota. This study investigates the effects of tamoxifen on gut microbiota c...

Full description

Bibliographic Details
Main Authors: Lars E. Hillege, David J. M. Barnett, Janine Ziemons, Romy Aarnoutse, Judith de Vos-Geelen, Robin van Geel, Maaike de Boer, Yvonne E. A. van Riet, Jeroen Vincent, John Penders, Marjolein L. Smidt
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Breast neoplasms
Antineoplastic agents
Postmenopausal
Online Access:https://doi.org/10.1038/s41598-025-91734-1

Internet

https://doi.org/10.1038/s41598-025-91734-1

Similar Items